On the 14th day, 17% of specimens belonging to the B-CAC group presented epidermis thickening Figure 13 as opposed to groups treated with BBS Figure 11 and polyglactin 910 Figure 12, whose percentages were 33% and 50% respectively.
En el 14° día, el 17% de los especímenes correspondientes al grupo de CAC-B, presentaban engrosamiento de la epidermis Figura 13 a diferencia de los grupos tratados con SNT Figura 11 y poliglactina 910 Figura 12 cuyos porcentajes fueron 33 y 50%respectivamente.